Your browser doesn't support javascript.
loading
Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future.
Whiting, Zak M; Yin, Jiazhen; de la Harpe, Sara M; Vernall, Andrea J; Grimsey, Natasha L.
Affiliation
  • Whiting ZM; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Yin J; Department of Chemistry, Division of Sciences, University of Otago, Dunedin, New Zealand.
  • de la Harpe SM; Department of Chemistry, Division of Sciences, University of Otago, Dunedin, New Zealand.
  • Vernall AJ; Department of Chemistry, Division of Sciences, University of Otago, Dunedin, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
  • Grimsey NL; Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Maurice Wilkins C
Trends Pharmacol Sci ; 43(9): 754-771, 2022 09.
Article in En | MEDLINE | ID: mdl-35906103
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids Limits: Humans Language: En Journal: Trends Pharmacol Sci Year: 2022 Document type: Article Affiliation country: New Zealand Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabinoids Limits: Humans Language: En Journal: Trends Pharmacol Sci Year: 2022 Document type: Article Affiliation country: New Zealand Country of publication: United kingdom